This week Royal Bank of Scotland entered into exclusive talks with a struggling SIV, a $6.6 billion fund run by Cheyne Capital, which may result in a refinancing.
Objective To investigate the efficacy of adaptive pressure support servo-ventilation (APSSV) on Cheyne-Stokes respiration (CSR) in congestive heart failure (CHF).